State Street’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10M Sell
58,203
-8,576
-13% -$1.48M ﹤0.01% 2602
2025
Q1
$10.4M Sell
66,779
-4,977
-7% -$776K ﹤0.01% 2506
2024
Q4
$9.88M Buy
71,756
+297
+0.4% +$40.9K ﹤0.01% 2636
2024
Q3
$10.7M Buy
71,459
+36,402
+104% +$5.44M ﹤0.01% 2559
2024
Q2
$4.78M Buy
35,057
+705
+2% +$96.1K ﹤0.01% 2951
2024
Q1
$5.19M Buy
34,352
+3,100
+10% +$469K ﹤0.01% 2910
2023
Q4
$3.94M Buy
31,252
+525
+2% +$66.1K ﹤0.01% 3056
2023
Q3
$2.88M Sell
30,727
-555
-2% -$52K ﹤0.01% 3171
2023
Q2
$2.79M Sell
31,282
-27,800
-47% -$2.48M ﹤0.01% 3261
2023
Q1
$6.33M Sell
59,082
-26,967
-31% -$2.89M ﹤0.01% 2893
2022
Q4
$10.5M Buy
86,049
+61,429
+250% +$7.5M ﹤0.01% 2665
2022
Q3
$2.54M Buy
24,620
+286
+1% +$29.5K ﹤0.01% 3340
2022
Q2
$2.26M Sell
24,334
-15,720
-39% -$1.46M ﹤0.01% 3436
2022
Q1
$4.7M Buy
40,054
+15,689
+64% +$1.84M ﹤0.01% 3209
2021
Q4
$3.28M Buy
24,365
+2,352
+11% +$316K ﹤0.01% 3449
2021
Q3
$3.51M Sell
22,013
-3,731
-14% -$595K ﹤0.01% 3413
2021
Q2
$3.39M Buy
25,744
+1,827
+8% +$240K ﹤0.01% 3409
2021
Q1
$3.08M Buy
23,917
+2,329
+11% +$300K ﹤0.01% 3255
2020
Q4
$3.61M Sell
21,588
-58
-0.3% -$9.69K ﹤0.01% 3121
2020
Q3
$3.34M Buy
21,646
+3,267
+18% +$504K ﹤0.01% 2982
2020
Q2
$2.72M Buy
18,379
+3,408
+23% +$504K ﹤0.01% 3059
2020
Q1
$1.69M Sell
14,971
-80,566
-84% -$9.07M ﹤0.01% 3125
2019
Q4
$13.3M Buy
95,537
+86,185
+922% +$12M ﹤0.01% 2380
2019
Q3
$901K Buy
9,352
+352
+4% +$33.9K ﹤0.01% 3418
2019
Q2
$1.04M Buy
+9,000
New +$1.04M ﹤0.01% 3415
2018
Q3
Sell
-13,755
Closed -$915K 3771
2018
Q2
$915K Sell
13,755
-968
-7% -$64.4K ﹤0.01% 3412
2018
Q1
$963K Sell
14,723
-3,735
-20% -$244K ﹤0.01% 3346
2017
Q4
$739K Sell
18,458
-294
-2% -$11.8K ﹤0.01% 3397
2017
Q3
$679K Buy
+18,752
New +$679K ﹤0.01% 3439